We are live on ! Find out more
PHVS icon

Pharvaris

28 hedge funds and large institutions have $406M invested in Pharvaris in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

0.09% less ownership

Funds ownership: 69.17%69.08% (-0.09%)

15% less funds holding

Funds holding: 3328 (-5)

34% less capital invested

Capital invested by funds: $617M → $406M (-$210M)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
28
Holders Change
-5
Holders Change %
-15.15%
% of All Funds
0.49%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
2
Increased
9
Reduced
6
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Ensign Peak Advisors
26
Ensign Peak Advisors
Utah
$91K
TRCT
27
Tower Research Capital (TRC)
New York
$11K +$12.7K +561 New
Bank of America
28
Bank of America
North Carolina
$10K +$1.14K +50 +10%
MWNA
29
Marshall Wace North America
New York
-$1.09M -39,008 Closed
PCM
30
Pinz Capital Management
New York
-$634K -22,650 Closed
ZP
31
Zimmer Partners
New York
-$420K -15,000 Closed
DKCM
32
Davidson Kempner Capital Management
New York
-$98K -3,500 Closed
RCMU
33
Rokos Capital Management (UK)
United Kingdom
-$68K -2,500 Closed
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
-$3K -116 Closed
UBS Group
35
UBS Group
Switzerland
-$1K -32 Closed

PHVS Hedge Fund Activity: Q2 2021 in Review

28 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q2 2021, worth a combined $406M — down 34% from $617M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PHVS and 2 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 9 added.

The largest buyer was Fidelity Investments, adding an estimated $11.1M. The largest seller was Foresite Capital Management V, cutting an estimated $6.81M.

  • 28 institutional investors held Pharvaris (PHVS) as of Q2 2021, down from 33 in Q1 2021.
  • Funds reported $406M of Pharvaris stock for Q2 2021, down 34% quarter-over-quarter.
  • 2 funds opened new Pharvaris positions in Q2 2021 and 7 closed out, a net change of -5 holders.
  • The largest Pharvaris buyer in Q2 2021 was Fidelity Investments, an estimated $11.1M added.
  • The largest Pharvaris seller in Q2 2021 was Foresite Capital Management V, an estimated $6.81M sold.

Based on aggregated 13F filings for Q2 2021.